Wills Eye Glaucoma Service
Philadelphia, Pennsylvania, 19107, United States
NCT Number: NCT00430287
The purpose of this study is to determine how well the DDLS (Disc Damage Likelihood Scale) (which is a method used by the eye doctor to evaluate how healthy the optic nerve is) measures up to the standard glaucoma tests: OCT (Optical Coherence Tomography), the HRT (Heidelberg Retinal Tomography) and the HVF (Humphrey Visual Field).
Looking for future studies?
Notify Me45 year–85 year
All sexes
Observational
Philadelphia, Pennsylvania, 19107, United States
The Disc Damage Likelihood Scale (DDLS) has been shown to be a reproducible method for clinicians to evaluate the optic nerve for glaucomatous damage and is highly correlated to diagnosis of glaucoma, severity of glaucoma as evidenced by visual field loss and Heidelberg Retina Tomography (HRT) evaluation. In comparison with the commonly used cup-disc ratio, the DDLS has less inter-observer variation and captures glaucomatous aspects of the optic nerve not assessed by the cup-disc ratio. The optic nerve imagers do not have the potential to completely replace the clinical examination of the optic nerve since they do not assess many critical features such as optic nerve pallor, hemorrhages, asymmetry of disc size, edema, etc. The DDLS presents the opportunity to provide a system to clinicians to increase the quality and objectivity of clinical optic nerve evaluation. The purpose of this study is to investigate the correlation of the DDLS grading to OCT, HRT and HVF testing of glaucomatous and normal optic nerves.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Wills Eye
Other
Correlation of DDLS Grading to OCT, HRT, and HVF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04014933
Eye Diseases, Glaucoma
Zurich, Canton of Zurich, Switzerland
View Trial DetailsNCT04475900
Astigmatism, Corneal Astigmatism
Dresden, Saxony, Germany
View Trial DetailsNCT01840202
Eye Diseases, Glaucoma
Leuven, Vlaams-Brabant, Belgium
View Trial DetailsNCT01802463
Eye Diseases, Glaucoma
Leuven, Flemish Brabant, Belgium
View Trial Details